Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Accepts healthy volunteers

Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan

ClinicalTrials.gov ID: NCT00121147

Public ClinicalTrials.gov record NCT00121147. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 6:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Comparison of the Additivity of Brinzolamide Ophthalmic Suspension, 1% (Azopt) and Brimonidine Tartrate Ophthalmic Solution, 0.15% (Alphagan P) to Travoprost Ophthalmic Solution, 0.004% (Travatan) in Patients With Elevated IOP on Travoprost. A Three Month Double-Masked, Multi-Center Trial in the United States

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the additive effect on eye pressure of Azopt and Alphagan P to Travatan.

Study identification

NCT ID
NCT00121147
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Hermann Eye Center
Other
Enrollment
200 participants

Conditions and interventions

Eligibility (public fields only)

Age range
35 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2003 (Type not available)
Primary completion
Not listed
Completion
Oct 2005 (Type not available)
Last update posted
Feb 24, 2006

2003 – 2005

United States locations

U.S. sites
21
U.S. states
14
U.S. cities
17
Facility City State ZIP Site status
Doheny Eye Institute Los Angeles California 90033-4666 —
The Eye Center Hamden Connecticut 06518 —
University of Florida Gainesville Florida 32610 —
Emory Healthcare Eye Center Atlanta Georgia 30322 —
Omni Eye Services Atlanta Georgia 30342 —
Northwestern University Chicago Illinois 60611 —
University of Illinois Eye and Ear Infirmary Chicago Illinois 60612 —
Indiana University School of Medicine Indianapolis Indiana 46202 —
Glaucoma Consultation Service Boston Massachusetts 02114 —
Kresge Eye Institute Detroit Michigan 48201 —
Mississippi Eye Associates Ocean Springs Mississippi 39564 —
Eyecare Ophthalmology PC Bethpage New York 11714 —
Mount Sinai School of Medicine New York New York 10029 —
Dean McGee Eye Institute Oklahoma City Oklahoma 73104 —
Wills Eye Institute Philadelphia Pennsylvania 19107 —
The Keystone Eye Associates Philadelphia Pennsylvania 19114 —
Glaucoma Associates of Texas Dallas Texas 75231 —
Baylor College of Medicine Houston Texas 77030 —
Hermann Eye Center Houston Texas 77030 —
Lone Star Eye Associates Sugarland Texas 77479 —
West Virginia University Eye Institute Morgantown West Virginia 26506 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00121147, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 24, 2006 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00121147 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →